No menu items!
Friday, June 5, 2026

National Biopharma Mission (NBM)

DBT-BIRAC supported indigenously developed DNA Vaccine Candidate by Zydus Cadila, approved for Phase III clinical trials

The Nation’s first indigenously developed DNA vaccine candidate against COVID-19, ZyCoV-D, by M/s Zydus Cadila has been approved by Drugs Controller General of India (DCGI), for conduct of the Phase III clinical trials. The candidate has been supported by...
- Advertisement -spot_img

Latest News

Zourney.in Bets on AI To Simplify India’s B2B Travel

India’s B2B travel market is still shaped by fragmented systems, manual coordination and slow turnaround times for agents. Sandeep...
- Advertisement -spot_img